Navigation Links
McNeil Consumer Healthcare Announces Plans for New Dosing Instructions for TYLENOL® Products
Date:7/28/2011

FORT WASHINGTON, Pa., July 28, 2011 /PRNewswire/ -- McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. ("McNeil") today announced plans for new dosing instructions lowering the maximum daily dose for single-ingredient Extra Strength TYLENOL® (acetaminophen) products sold in the U.S. from 8 pills per day (4,000 mg) to 6 pills per day (3,000 mg). The change is designed to help encourage appropriate acetaminophen use and reduce the risk of accidental overdose.

Acetaminophen, the active ingredient in TYLENOL®, can be found in more than 600 over-the-counter (OTC) and prescription medications, such as TYLENOL®, SUDAFED® Triple Action™, NyQuil®, Percocet® and Vicodin®.*   Acetaminophen is used by more than 50 million Americans each week to treat conditions such as pain, fever and aches and pains associated with cold and flu symptoms.

"Acetaminophen is safe when used as directed," said Edwin Kuffner, M.D., Vice President of OTC Medical Affairs and Clinical Research at McNeil Consumer Healthcare. "But, when too much is taken (overdose), it can cause liver damage.  Some people accidentally exceed the recommended dose when taking multiple products at the same time, often without realizing they contain acetaminophen or by not reading and following the dosing instructions.  McNeil is revising its labels for products containing acetaminophen in an attempt to decrease the likelihood of accidental overdosing in those instances."

McNeil has informed the U.S. Food and Drug Administration (FDA) that the new dosing instructions will appear on Extra Strength TYLENOL® product packages in the U.S. beginning in the fall of 2011.  McNeil will also be lowering the maximum daily dose for Regular Strength TYLENOL® and other adult acetaminophen-containing products beginning in 2012. Consumers can continue to use their TYLENOL® and other adult acetaminophen-containing products as currently labeled. The company is working closely with other manufacturers of acetaminophen products to help ensure consistency in dosing instructions.  

In addition to the new dosing instructions on the OTC label, the makers of TYLENOL® recently launched Get Relief Responsibly™, a national initiative designed to educate consumers about the appropriate use of prescription and OTC medications, particularly those containing acetaminophen, and the importance of reading and following medication labels. As a part of this initiative, the TYLENOL® website has been enhanced to include interactive tools to help consumers identify products that contain acetaminophen (www.tylenol.com/getreliefresponsibly).  

McNeil also announced that it will be introducing Bottle Cap Messaging on select Extra Strength TYLENOL® products.  The Bottle Cap Messaging is a message printed directly on bottle caps to remind consumers to always read and follow the label instructions.  This messaging is planned to appear on select Extra Strength TYLENOL® caps starting in 2012.  

About McNeil Consumer Healthcare 

McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. markets a broad range of well-known and trusted OTC products in the United States, including its complete line of TYLENOL® (acetaminophen) products.  The TYLENOL® product line consists of hundreds of products across a variety of adult and pediatric pain categories including: arthritis pain, pain with accompanying sleeplessness and upper respiratory.  Other McNeil brands include BENADRYL® allergy medicines; IMODIUM® A-D anti-diarrheal; MOTRIN® IB; ROLAIDS® antacid products; SUDAFED® and SUDAFED PE® nasal decongestants; and ZYRTEC® and ZYRTEC-D®12-HOUR®.

(This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995.  These statements are based on current expectations of future events.  If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of McNEIL-PPC, Inc. and/or Johnson & Johnson.  Risks and uncertainties include, but are not limited to, general industry conditions and competition; economic factors, such as interest rate and currency exchange rate fluctuations; technological advances and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations; trends toward health care cost containment; and increased scrutiny of the healthcare industry by government agencies.  A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended January 2, 2011.  Copies of this Form 10-K, as well as subsequent filings, are available online at www.sec.gov, www.jnj.com or on request from Johnson & Johnson.  Neither McNEIL-PPC, Inc. nor Johnson & Johnson undertake to update any forward-looking statements as a result of new information or future events or developments.)

*The third-party trademarks used herein are registered trademarks of their respective owners and not McNEIL-PPC, Inc.

CONSUMER INQUIRIES:
1-877-414-7711


'/>"/>
SOURCE McNeil Consumer Healthcare
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Isis Earns $5 Million Milestone Payment From Ortho-McNeil, Inc. for Initiation of Phase 1 Study of ISIS 325568
2. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
3. McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP
4. AUDIO from Medialink and Ortho-McNeil-Janssen Pharmaceuticals Inc.: Getting Ready for Cold and Flu Season
5. McNeil Consumer Healthcare Announces a Voluntary Nationwide Recall of All Lots of TYLENOL(R) Arthritis Pain 100 Count With EZ-OPEN CAP
6. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Agrees to $75 Million Settlement for Topamax(R) False Claims Lawsuit
7. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Resolves Investigation of Past TOPAMAX(R) Marketing and Promotional Activities
8. Ortho-McNeil Pharmaceutical, LLC Pleads Guilty to Illegal Promotion of Topamax and is Sentenced to Criminal Fine of $6.14 Million
9. The Pittsburgh Life Sciences Greenhouse Congratulates Diamyd Medical on Its Agreement with Ortho-McNeil-Janssen Pharmaceuticals to Develop Diabetes Therapy
10. Ortho-McNeil-Janssen Pharmaceuticals, Inc. Announces Oncology Research Collaboration Agreement with the Koch Institute for Integrative Cancer Research at MIT
11. McNeil Consumer Healthcare Announces Voluntary Recall of One Product Lot of TYLENOL® 8 Hour Caplets 50 Count Sold in the United States and Puerto Rico
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2017)...  Demonstrating its commitment to representing research- based ... Pharmaceutical Research and Manufacturers of America (PhRMA) today ... now have to meet new research and development ... join PhRMA. "By putting in place ... clear message that being a member of PhRMA ...
(Date:5/8/2017)... , May 8, 2017  Diplomat Pharmacy, Inc. (NYSE: ... Inc. ("WRB"), a health care service center company ... WRB specializes in relationship management programs for leading ... WRB will join Envoy ... support services for manufacturers, biotech firms, and other service ...
(Date:5/4/2017)... , May 4, 2017  Fortuna Fix Inc. (" Fortuna ... be the first to eliminate the need for embryonic and ... to treat neurodegenerative diseases. Fortuna announced ... Professor Michael Fehlings , MD, PhD; Father Kevin ... MD, MPH; and Professor James Giordano , PhD. ...
Breaking Medicine Technology:
(Date:5/24/2017)... , ... May 24, 2017 , ... ... is offering holistic pediatric dentistry options for its patients on Long Island, New ... patient’s entire physical well being, and is one of the biggest trends in ...
(Date:5/24/2017)... Chicago, IL (PRWEB) , ... May 24, 2017 ... ... of the most prominent for-profit and nonprofit hospitals and health systems in the ... have turned around their institutions, led professional organizations and been instrumental in developing ...
(Date:5/24/2017)... ... ... Technique, technique, technique – with a dash of common sense. Those are ... exercise or simply lifting heavy objects, advises Dr. Kaliq Chang, interventional pain management specialist ... “Improper technique in lifting anything heavy or an attempt to lift too much can ...
(Date:5/23/2017)... ... May 23, 2017 , ... MDLand International (MDLand), a leading ... that its iClinic V12.2 solution has achieved approval from National Center for Quality ... 2017 standards which emphasize team-based care with a significant focus on the care ...
(Date:5/23/2017)... ... ... Allegheny Health Network and the Alexis Joy D’Achille Foundation ... Health at West Penn Hospital , a unique facility that will offer the ... Construction of the Center is underway with a scheduled opening in the fall ...
Breaking Medicine News(10 mins):